Does TELMISARTAN Cause Benign prostatic hyperplasia? 19 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Benign prostatic hyperplasia have been filed in association with TELMISARTAN (telmisartan). This represents 0.3% of all adverse event reports for TELMISARTAN.
19
Reports of Benign prostatic hyperplasia with TELMISARTAN
0.3%
of all TELMISARTAN reports
5
Deaths
12
Hospitalizations
How Dangerous Is Benign prostatic hyperplasia From TELMISARTAN?
Of the 19 reports, 5 (26.3%) resulted in death, 12 (63.2%) required hospitalization, and 9 (47.4%) were considered life-threatening.
Is Benign prostatic hyperplasia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TELMISARTAN. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does TELMISARTAN Cause?
Drug ineffective (685)
Dizziness (569)
Dyspnoea (556)
Headache (508)
Fall (500)
Nausea (486)
Hypertension (477)
Blood pressure increased (473)
Diarrhoea (467)
Malaise (458)
What Other Drugs Cause Benign prostatic hyperplasia?
TADALAFIL (596)
TAMSULOSIN (304)
FINASTERIDE (266)
PANTOPRAZOLE (261)
PREDNISONE (257)
ALBUTEROL (254)
ASPIRIN (243)
TIOTROPIUM (235)
RAMIPRIL (193)
AMLODIPINE (179)
Which TELMISARTAN Alternatives Have Lower Benign prostatic hyperplasia Risk?
TELMISARTAN vs TELOTRISTAT ETHYL
TELMISARTAN vs TEMAZEPAM
TELMISARTAN vs TEMODAR
TELMISARTAN vs TEMOZOLOMIDE
TELMISARTAN vs TEMSIROLIMUS